You have 9 free searches left this month | for more free features.

target range glucose values

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 1 Diabetes Trial in Worldwide (Insulin glargine, 300 U/ml, Insulin degludec, 100U/ml, Background therapy: Rapid acting

Completed
  • Type 1 Diabetes Mellitus
  • Insulin glargine, 300 U/ml
  • +2 more
  • Dallas, Texas
  • +6 more
Oct 19, 2022

Time Spent In Target Glucose Range in T2D Diabetes in Pregnancy

Recruiting
  • Diabete Type 2
  • Pregnancy in Diabetic
  • Dexcom Continuous Glucose Monitoring
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Nov 21, 2023

Type 1 Diabetes Trial in Atlanta, West Des Moines, Minneapolis (LY900014, Insulin Degludec)

Completed
  • Type 1 Diabetes
  • Atlanta, Georgia
  • +2 more
May 6, 2022

Type 2 Diabetes, Hip Osteoarthritis, Knee Osteoarthritis Trial in Philadelphia (DexCom G6 continuous glucose monitor)

Terminated
  • Type 2 Diabetes
  • +2 more
  • DexCom G6 continuous glucose monitor
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 15, 2022

Hyperglycemia, Hypoglycemia, Critical Illness Trial (Continuous glucose monitoring, Point of care glucose monitoring)

Not yet recruiting
  • Hyperglycemia
  • +3 more
  • Continuous glucose monitoring
  • Point of care glucose monitoring
  • (no location specified)
Jun 28, 2022

Diabetes, Type 2 Trial in United States (Blinded CGM, real-time CGM)

Recruiting
  • Diabetes Mellitus, Type 2
  • Blinded CGM
  • real-time CGM
  • Aurora, Colorado
  • +5 more
Nov 23, 2022

Type 1 Diabetes Trial in Salt Lake City (FAMS-T1D, Digital resources for diabetes)

Recruiting
  • Type 1 Diabetes
  • FAMS-T1D
  • Digital resources for diabetes
  • Salt Lake City, Utah
    University of Utah
Apr 7, 2023

Prevalence of Hyperandrogenism in Type 1 Diabetes

Recruiting
  • Type 1 Diabetes
  • +5 more
  • Clinical hyperandrogenism assessment
  • +20 more
  • Madrid, Spain
    Hospital Universitario Ramón y Cajal
Mar 14, 2022

Blood Glucose, Critical Care Trial in Prague (Dexcom G6 continuous glucose monitor, Blood glucose measurements according to

Recruiting
  • Blood Glucose
  • Critical Care
  • Dexcom G6 continuous glucose monitor
  • Blood glucose measurements according to standards of care
  • Prague, Czechia
    Institute for Clinical and Experimental Medicine
Oct 31, 2022

Type 1 Diabetes Trial in Valencia (Automated insulin delivery system algorithm with a dual-hormone configuration (insulin and

Not yet recruiting
  • Type 1 Diabetes
  • Automated insulin delivery system algorithm with a dual-hormone configuration (insulin and glucagon) for glucose control
  • Automated insulin delivery system with a single-hormone configuration (insulin) with rescue carbohydrate recommendations for glucose control
  • Valencia, Spain
    INCLIVA
Oct 11, 2023

Blood Glucose, Humans, Critical Care Trial in Stockholm (subcutaneous continuous glucose sensor)

Recruiting
  • Blood Glucose
  • +2 more
  • subcutaneous continuous glucose sensor
  • Stockholm, Sweden
    Karolinska University Hospital
Feb 15, 2022

Type1diabetes Trial (Happy Bob, CGM)

Not yet recruiting
  • Type1diabetes
  • Happy Bob
  • CGM
  • (no location specified)
Dec 15, 2022

Type1 Diabetes, Obesity Trial in Milan (Microbiome-targeted diet, Usual care diet)

Recruiting
  • Type1 Diabetes
  • Obesity
  • Microbiome-targeted diet
  • Usual care diet
  • Milan, Milano, Italy
  • +1 more
Mar 1, 2023

Diabetes, Type 1 Trial in Valencia (Aerobic session)

Recruiting
  • Diabetes Mellitus, Type 1
  • Aerobic session
  • Valencia, Spain
    Rodrigo Martin-San Agustin
Oct 17, 2023

Type 1 Diabetes Trial (Empagliflozin, Placebo)

Not yet recruiting
  • Type 1 Diabetes
  • (no location specified)
Aug 31, 2023

Hyperglycemia, Renal Transplant Complication Primary Non-Function, Diabetes Trial (Semaglutide 14 MG [Rybelsus], Placebo)

Not yet recruiting
  • Hyperglycemia
  • +2 more
  • Semaglutide 14 MG [Rybelsus]
  • Placebo
  • (no location specified)
Feb 1, 2023

Diabetes, Type 2, Hyperglycemia Stress, Hypoglycemia Trial (Real-Time CGM, Capillary blood glucose testing with masked CGM)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • Real-Time CGM
  • Capillary blood glucose testing with masked CGM
  • (no location specified)
Dec 13, 2022

Type 2 Diabetes Trial (Continuous glucose monitor, Traditional glucometer)

Not yet recruiting
  • Type 2 Diabetes
  • Continuous glucose monitor
  • Traditional glucometer
  • (no location specified)
Mar 8, 2023

Kidney Transplant; Complications, Diabetes, Type 2, Insulin Dependent Diabetes Trial in Sacramento (Dexcom G6, Dexcom G6 blinded

Recruiting
  • Kidney Transplant; Complications
  • +2 more
  • Dexcom G6
  • Dexcom G6 blinded sensor
  • Sacramento, California
    UC Davis Health
Aug 4, 2022

Type 2 Diabetes, Acute Myocardial Infarction, Acute Myocardial Infarction With ST Elevation Trial (Dexcom G6 Continuous Glucose

Not yet recruiting
  • Type 2 Diabetes
  • +3 more
  • Dexcom G6 Continuous Glucose Monitoring System
  • (no location specified)
Jun 21, 2022

Hypoglycemia Trial in Gentofte (Pump therapy. MiniMed 780G, Medtronic Diabetes, Northridge, CA)

Completed
  • Hypoglycemia
  • Insulin pump
  • Gentofte, Denmark
    Steno Diabetes Center Copenhagen
Nov 8, 2022

Pre-Gestational Diabetes, Type2diabetes, Pregnancy in Diabetic Trial in Columbus (DEXCOM G6 PRO Continuous Glucose Monitor,

Not yet recruiting
  • Pre-Gestational Diabetes
  • +3 more
  • DEXCOM G6 PRO Continuous Glucose Monitor
  • +3 more
  • Columbus, Ohio
    The Ohio State University Wexner Medical Center OB/GYN Maternal
Dec 14, 2022

Type 2 Diabetes Trial in San Francisco (FreeStyle Libre Continuous Glucose Monitor System)

Not yet recruiting
  • Type 2 Diabetes
  • FreeStyle Libre Continuous Glucose Monitor System
  • San Francisco, California
    University of California San Francisco (UCSF)
Oct 19, 2023

Type 2 Diabetes Trial in Palo Alto (Continuous Glucose Monitor, Patient Reported Outcome Questionnaires)

Enrolling by invitation
  • Type 2 Diabetes
  • Continuous Glucose Monitor
  • Patient Reported Outcome Questionnaires
  • Palo Alto, California
    Stanford Children's Health
Oct 12, 2022

Type1 Diabetes Trial in Stanford, New York, Charlottesville (Continuous Glucose Monitor (CGM)+Decision Support System (DSS),

Completed
  • Type1 Diabetes Mellitus
  • Continuous Glucose Monitor (CGM)+Decision Support System (DSS)
  • Continuous Glucose Monitor (CGM) alone
  • Stanford, California
  • +2 more
Nov 8, 2022